Poland

A snapshot of PrEP scale-up, registration and resources for Poland.

1,500-2,000

Estimated Number of Current PrEP Users

Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

Data Updated: December 31, 2018

Drug Registration Status

Gilead's Truvada (TDF/FTC) registration

Approved

Generic versions of TDF/FTC for prevention

Approved

Types of Projects

National level — PrEP availability in government clinics

PrEP Watch is a clearinghouse for PrEP data, research, cost, access, implementation and advocacy efforts across the globe.Learn more about PrEP

PrEP Watch was created and is maintained by AVAC, a non-profit organization based in New York that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of new and emerging HIV prevention options as part of a comprehensive response to the HIV/AIDS pandemic. AVAC receives no money from pharmaceutical companies, including Gilead Sciences. If you have a comment or suggestion regarding the content of this site, click here to contact us. Read our privacy policy.